Showing 3031-3040 of 23149 results for "".
Addressing Unmet Needs in First-Line mTNBC Care
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/addressing-unmet-needs-in-first-line-mtnbc-care/48710/Metastatic triple-negative breast cancer (mTNBC) is a highly aggressive disease with significant unmet needs in the first-line treatment setting, which means that making early and informed decisions is critical. Joining Dr. Jennifer Caudle to break down emerging strategies, evolving standards of carReevaluating Race in Spirometry: Advancing Equity in Pulmonary Risk Assessment
https://reachmd.com/programs/project-oncology/reevaluating-race-in-spirometry-advancing-equity-in-pulmonary-risk-assessment/39035/Race-based spirometry adjustments have long influenced pulmonary risk assessments, often underestimating disease severity in Black patients. Hear from Dr. Ajay Sheshadri as he examines the historical misuse of race in lung function testing, explores race-neutral modeling in surgical risk prediction,Educating Patients and Caregivers on Post-Surgical Wound Care
https://reachmd.com/programs/clinicians-roundtable/educating-patients-and-caregivers-on-post-surgical-wound-care/36424/Teaching patients and their caregivers how to properly manage a wound after surgery is critical for preventing infection and ensuring safe and effective outcomes. Learn practical educational strategies that can help make the healing process as smooth as possible with Ms. Kara Couch. She's a certifieDifferentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
https://reachmd.com/programs/project-oncology/differentiating-large-cell-neuroendocrine-carcinoma-from-other-lung-cancers/36459/Properly differentiating between small cell lung cancer, large cell neuroendocrine carcinoma, and other lung cancer subtypes is important in choosing the right treatment for patients. Hear Dr. Balazs Halmos discuss key differences in the diagnostic and therapeutic processes of these cancers and howRewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
https://reachmd.com/programs/project-oncology/rewriting-the-prognosis-advances-in-endometrial-cancer-diagnosis-and-treatment/36394/The treatment landscape for endometrial cancer is undergoing a critical transformation as rising incidence, earlier onset, and persistent disparities—especially among younger patients and patients of color—demand urgent attention. Hear from Dr. Kathleen Moore as she unpacks the role of molecular subPBA Treatment May Reverse Signs of Alzheimer’s Disease
https://reachmd.com/programs/neurofrontiers/pba-treatment-may-reverse-signs-of-alzheimers-disease/17826/Tune in to hear how a fatty acid molecule is being studied in Alzheimer’s disease for its potential impacts on memory retention.How Do You Approach Obesity During an Office Visit?
https://reachmd.com/programs/everyday-family-medicine/how-do-you-approach-obesity-during-office-visit/7432/Approaching the topic of body weight with patients is a sensitive issue. It can be challenging for providers to discuss health issues related to excess weight while also remaining sensitive to terminology and language that may offend patients. Host Dr. Jennifer Caudle welcomes Dr. Adarsh Gupta to prBiomarkers for Ulcerative Colitis Management: A Review of the AGA Guidelines
https://reachmd.com/programs/gi-insights/biomarkers-for-ulcerative-colitis-management-a-review-of-the-aga-guidelines/15446/Catch up on what the latest guideline from the AGA says about the role of biomarkers for the management of ulcerative colitis.Perioperative Immunotherapy Strategies in Resectable NSCLC Care
https://reachmd.com/programs/project-oncology/perioperative-immunotherapy-resectable-nsclc/49111/The treatment paradigm for early-stage resectable non-small cell lung cancer (NSCLC) is rapidly evolving with the integration of perioperative immunotherapy. To learn more about the structure, rationale, and clinical impact of these regimens, Dr. Charles Turck speaks with Dr. Martin Dietrich, AssistPersonalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
https://reachmd.com/programs/project-oncology/personalized-treatment-pathways-in-endometrial-cancer-a-molecular-approach/36395/Precision oncology in endometrial cancer is accelerating, with ongoing studies exploring the potential to guide treatment based on molecular subgroups. Dr. Kathleen Moore discusses emerging strategies, including antibody-drug conjugates, immune checkpoint inhibitors, and hormonal and small-mol